Strategy, transactions and commercial growth.
I am a pharmacist by training and an MBA, with 14+ years of post-MBA experience advising corporates and investors on growth, investment and commercial questions, with particular depth across healthcare and MedTech.
I currently work as a Director with Monitor Deloitte. My experience spans growth and corporate strategy, portfolio choices, market entry, go-to-market, commercial transformation, partnerships, commercial due diligence and value-creation assessment.
Healthcare and MedTech form the core of my sector experience. I have worked across medical devices, diagnostics and IVD, healthcare services, hospital and ambulatory models, renal care and health-tech, advising both corporate management teams and investors.
In corporate contexts, my work has included multi-year growth strategy, market prioritisation, commercial acceleration, market entry, institutional and government sales, partnerships and adjacent-growth evaluation. In investor contexts, I have worked on acquisition screening and buy-side commercial diligence, testing market attractiveness, competitive positioning, business-plan achievability, scalability, downside risks and potential growth and EBITDA-improvement levers.
My experience spans India, the Middle East and other international markets, including cross-border strategy and partnership questions involving markets such as the UAE, Saudi Arabia and selected developed-market corridors.
How my role has evolved
As my responsibilities have grown, my role has increasingly extended beyond engagement delivery. I lead teams, develop propositions, build senior relationships, originate opportunities and contribute to the development of a broader healthcare and MedTech consulting platform.
I am most useful where a broad strategic question has to be converted into a practical set of choices: where to play, how to win, what to diligence, which risks matter, where value can be created and what management should do next.
My preference is for work that combines market evidence, sector understanding and commercial judgement rather than analysis for its own sake. Over time, I have become particularly interested in situations where strategy, transactions and commercial execution intersect.
Selected capabilities
- Growth & Corporate Strategy
- Growth strategy, portfolio choices, market entry, adjacency assessment, market prioritisation, business planning and new-business evaluation
- Transactions
- Commercial due diligence, target screening, market assessment, competitive positioning, business-plan testing and investment evaluation
- Go-to-Market & Commercial Transformation
- GTM strategy, sales acceleration, channel strategy, institutional and government markets, commercial excellence, pricing and partnerships
- Value Creation
- Identification of revenue-growth and EBITDA-improvement opportunities, market expansion, pricing, sales effectiveness and post-investment priorities
- Leadership
- Senior client relationships, engagement leadership, team development, proposition building, opportunity origination and practice contribution
- Sectors
- Geographies
- India · Middle East · Europe · selected international markets
- Background
- Bachelor of Pharmacy · MBA, TAPMI